Syndax Pharmaceuticals (SNDX) Non-Current Assets (2015 - 2026)
Syndax Pharmaceuticals (SNDX) recorded Non-Current Assets of $28.61 million in Q2 2026, down 55.6% from $64.47 million a year earlier.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Non-Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Syndax Pharmaceuticals reported Non-Current Assets of $1.63 million, down 98.7% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of -1.5% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $121.76 million in FY2024 (+280.4%), $32 million in FY2023 (+329.6%), $7.45 million in FY2022 (+490.8%) and $1.26 million in FY2021 (-27.9%).
- Quarterly Non-Current Assets has ranged from $1.25 million in Q3 2021 to $121.76 million in Q4 2024 over the past five years.
- On a year-over-year basis, Non-Current Assets has declined for three consecutive quarters, with growth averaging 24.9% over the last eight quarters.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 787.6% in Q3 2023, against a decline of 98.7% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.49 million (Q1 2026), $1.63 million (Q4 2025) and $21.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Syndax Pharmaceuticals | 1.59 Bn | -137.74 Mn | 69.58 Mn | 28.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.61 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 21.96 Mn |
| Jun 30, 2025 | 64.47 Mn |
| Mar 31, 2025 | 91.96 Mn |
| Dec 31, 2024 | 121.76 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 30.89 Mn |
| Mar 31, 2024 | 89.13 Mn |
| Dec 31, 2023 | 32.00 Mn |
| Sep 30, 2023 | 18.25 Mn |
| Jun 30, 2023 | 22.26 Mn |
| Mar 31, 2023 | 18.32 Mn |
| Dec 31, 2022 | 7.45 Mn |
| Sep 30, 2022 | 2.06 Mn |
| Jun 30, 2022 | 14.15 Mn |
| Mar 31, 2022 | 2.17 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.25 Mn |
API Access
Syndax Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();